Treatment of subclinical congenital toxoplasmosis by sulfadiazine and pyrimethamine continuously during 1 year: apropos of 46 cases (Q33341238)

25 July 2017

Treatment of subclinical congenital toxoplasmosis by sulfadiazine and pyrimethamine continuously during 1 year: apropos of 46 cases (English)

1 reference

25 July 2017

0 references

0 references

0 references

congenital toxoplasmosis

1 reference

1 reference

Kieffer F

1

1 reference

25 July 2017

Thulliez P

2

1 reference

25 July 2017

Brézin A

3

1 reference

25 July 2017

Nobre R

4

1 reference

25 July 2017

Romand S

5

1 reference

25 July 2017

Yi-Gallimard E

6

1 reference

25 July 2017

Voyer M

7

1 reference

25 July 2017

Magny JF

8

1 reference

25 July 2017

language of work or name

1 reference

1 January 2002

1 reference

25 July 2017

Archives de Pediatrie

1 reference

25 July 2017

9

1 reference

25 July 2017

1

1 reference

25 July 2017

7-13

1 reference

In utero treatment of toxoplasmic fetopathy with the combination pyrimethamine-sulfadiazine.

25 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0929-693X%2801%2900687-X

7 January 2021

Fetal toxoplasmosis: outcome of pregnancy and infant follow-up after in utero treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0929-693X%2801%2900687-X

7 January 2021

Treatment of toxoplasmosis during pregnancy: a multicenter study of impact on fetal transmission and children's sequelae at age 1 year.

1 reference

https://api.crossref.org/works/10.1016%2FS0929-693X%2801%2900687-X

7 January 2021

Neonatal serologic screening and early treatment for congenital Toxoplasma gondii infection. The New England Regional Toxoplasma Working Group

1 reference

https://api.crossref.org/works/10.1016%2FS0929-693X%2801%2900687-X

7 January 2021

Pyrimethamine-sulfadoxine treatment of congenital toxoplasmosis: follow-up of 78 cases between 1980 and 1997. Reims Toxoplasmosis Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0929-693X%2801%2900687-X

7 January 2021

Early and longitudinal evaluations of treated infants and children and untreated historical patients with congenital toxoplasmosis: the Chicago Collaborative Treatment Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0929-693X%2801%2900687-X

7 January 2021

Pharmacokinetics of spiramycin in the rhesus monkey: transplacental passage and distribution in tissue in the fetus

1 reference

https://api.crossref.org/works/10.1016%2FS0929-693X%2801%2900687-X

7 January 2021

Prenatal diagnosis of congenital toxoplasmosis with a polymerase-chain-reaction test on amniotic fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0929-693X%2801%2900687-X

7 January 2021

Serologic rebounds after one-year-long treatment for congenital toxoplasmosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0929-693X%2801%2900687-X

7 January 2021

[Study of developing clinical outbreak and serological rebounds in children with congenital toxoplasmosis and follow-up during the first 2 years of life]

1 reference

https://api.crossref.org/works/10.1016%2FS0929-693X%2801%2900687-X

7 January 2021

Eye manifestations of congenital toxoplasmosis

1 reference

https://api.crossref.org/works/10.1016%2FS0929-693X%2801%2900687-X

7 January 2021

Value of cerebrospinal fluid cytochemical examination for the diagnosis of congenital toxoplasmosis at birth in France

1 reference

https://api.crossref.org/works/10.1016%2FS0929-693X%2801%2900687-X

7 January 2021

Congenital toxoplasmosis: systematic review of evidence of efficacy of treatment in pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0929-693X%2801%2900687-X

7 January 2021

Prenatal management of 746 pregnancies at risk for congenital toxoplasmosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0929-693X%2801%2900687-X

7 January 2021

Termination of pregnancy for maternal toxoplasmosis

1 reference

https://api.crossref.org/works/10.1016%2FS0929-693X%2801%2900687-X

7 January 2021

Prenatal diagnosis using polymerase chain reaction on amniotic fluid for congenital toxoplasmosis

1 reference

https://api.crossref.org/works/10.1016%2FS0929-693X%2801%2900687-X

7 January 2021

Results of 20-year follow-up of congenital toxoplasmosis

1 reference

https://api.crossref.org/works/10.1016%2FS0929-693X%2801%2900687-X

7 January 2021

Evaluation of the Effect of Drugs on the Cyst Form of Toxoplasma gondii

1 reference

https://api.crossref.org/works/10.1016%2FS0929-693X%2801%2900687-X

7 January 2021

10.1016/S0929-693X(01)00687-X

Identifiers

DOI

1 reference

25 July 2017

1 reference